RESUMEN
The antitumor activities of triazine dendrimers bearing paclitaxel, a well-known mitotic inhibitor, are evaluated in SCID mice bearing human prostate cancer xenografts. To increase the activity of a first generation prodrug 1 that contained twelve paclitaxel molecules tethered via an ester linkage, the new construct described here, prodrug 2, tethers paclitaxel with linkers containing both an ester and disulfide. While PEGylation is necessary for solubility, and may improve biocompatibility and increase plasma half-life, it increases the heterogeneity of the sample with an average of eight to nine PEG chains (2 kDa each) incorporated. The heterogeneous population of PEGylated materials was used without fractionation based on models obtained from molecular dynamics simulations. Three models were examined; hexaPEGylated, nonaPEGylated, and dodecaPEGylated constructs. Intravenous delivery of prodrug 2 was performed by single, double or triple dosing regimes with doses spaced by one week. The doses varied from 50 mg of paclitaxel/kg to 200 mg of paclitaxel/kg. Tumor growth arrest and regression was observed over the 10-week treatment period without mortality for mice treated with the 50 mg of paclitaxel/kg treated three times.
Asunto(s)
Antineoplásicos/química , Antineoplásicos/uso terapéutico , Dendrímeros/química , Simulación de Dinámica Molecular , Paclitaxel/química , Paclitaxel/uso terapéutico , Triazinas/química , Animales , Línea Celular Tumoral , Humanos , Masculino , Ratones , Ratones Desnudos , Ratones SCID , Neoplasias de la Próstata/tratamiento farmacológico , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Ophthalmology research has identified a relationship between human placenta and eye tissue. Placental amniotic membrane provides structural healing properties that help restore vision in patients with ocular disease that has been unresponsive to medical treatment. The pathway from donor placenta retrieval to amniotic membrane transplantation (AMT) involves perioperative nurses from obstetrics and ophthalmology departments who are well versed in federal regulations and eye or tissue bank standards. Perioperative nurses can promote recycling of placentas for preservation and facilitate optimal surgical outcomes for patients undergoing AMT, as well as provide these patients with emotional support and education.